A new study from The University of Texas Medical Branch at Galveston department of Obstetrics and Gynecology has found that
The physician’s white coat: Iconic and comforting or likely covered in germs?
Home » Diseases and Conditions »
Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased
Real-time foot-and-mouth strategy to better fight disease
Future outbreaks of foot-and-mouth (FMD) disease can be combatted quickly and efficiently from early on — when authorities have minimal
New treatment for ultra-rare disease, alkaptonuria
A new study published in Molecular Genetics and Metabolism, conducted by a Liverpool based research collaboration involving the University of
Scientists discover potential therapy for human copper metabolism disorders
Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a discovery by a research
New system can identify drugs to target ‘undruggable’ enzymes critical in many diseases
A new drug discovery system allows scientists to specifically target members of an important family of enzymes, called phosphatases, which
Medical errors in the emergency room: Understanding why: 250,000 deaths per year are caused by medical error
Medical errors are estimated to cause 250,000 deaths per year in the US. Previously, research on admitted patients suggested that
Fitness trackers prove helpful in monitoring cancer patients: Study shows wearable devices can help assess quality of life and daily functioning during treatment
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment,
Heart attack risk on the rise for pregnant women and death rate remains high
The risk of having a heart attack while pregnant, giving birth, or during the two months after delivery, continues to
Long-term effectiveness of therapy for common cause of kidney failure
New research provides support for the long-term efficacy of a drug used to treat in patients with autosomal dominant polycystic